|
purple_matte.gif)
|
Why
is thimerosal used as a preservative in some vaccines?
Thimerosal is used as a preservative in some multi-dose vials
of vaccines to prevent contamination. Preservatives are not required
for vaccines in single-dose vials. As a preservative, thimerosal
is added at the end of the production process to the bulk or final
container to prevent contamination after multi-dose vials are
opened.
Until 1999, vaccines given to infants to protect them against diphtheria, tetanus, pertussis, Haemophilus influenzae type B (Hib), and Hepatitis B contained thimerosal as a preservative. Today, according to the U.S. Food and Drug Administration, the only vaccines routinely recommended for children 6 years of age and younger that contain thimerosal are: one vaccine for DTaP, and three vaccines for influenza (flu). These four vaccines contain only trace amounts of thimerosal. |
Top |
If
thimerosal was used in vaccines for many years, why did it become
a concern?
The Food and Drug Administration (FDA) Modernization Act of 1997
called for the FDA to review and assess the risk of all
mercury containing food and drugs. As part of this effort, the
FDA conducted a review of mercury content in vaccines.
|
Top |
What
recommendations did the Federal government make in 1999 with respect
to thimerosal in vaccines?
A review conducted by the FDA concluded that the use of thimerosal as a preservative in vaccines might result in the intake of mercury during the first 6 months of life that exceeds the Environmental Protection Agency (EPA), but not the FDA, the Agency for Toxic Substances and Disease Registry (ATSDR), or the World Health Organization (WHO) guidelines for methylmercury intake (Ball et. al., 2001). Thimerosal contains ethylmercury. Methylmercury is a related compound and has been more thoroughly researched than ethylmercury. Thus, federal safety standards are based on information we have about methylmercury.
FDA's review found no evidence of harm caused by doses of thimerosal in vaccines, except for minor local reactions (Ball et. al., 2001). Nevertheless, in July 1999 the Public Health Service Agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal levels in vaccines should be reduced or eliminated as a precautionary measure, and the FDA committed to expediting the review of new vaccines that do not contain thimerosal. |
| Top |
What
progress has been made since July 1999 in removing thimerosal
from vaccines routinely recommended for infants?
Substantial progress has been made in the effort to reduce thimerosal
exposure from vaccines. Today, with the exception of some flu
vaccines, none of the vaccines used in the U.S. to protect preschool
aged children against 12 infectious diseases contain thimerosal
as a preservative. The vaccines with trace amounts of thimerosal
licensed to date contain less than 0.5 micrograms of mercury per
dose, that is, a given dose of vaccine contains less than 1 part
per million.
Prior to the recent
initiative to reduce or eliminate thimerosal from childhood vaccines,
the maximum cumulative exposure to mercury via routine childhood
vaccinations during the first six months of life was 187.5 micrograms.
With the newly formulated vaccines, the maximum cumulative exposure
during the first six months of life will now be less than three
micrograms of mercury; this represents a greater than 98 percent
reduction in the amount of mercury a child would receive from
vaccines in the first six months of life. Influenza (flu) vaccine
is not given until six months or older.
|
Top |
Are
children getting toxic levels of mercury from vaccines?
No.
There is no evidence of harm caused by the minute doses of thimerosal
in vaccines, except for minor effects like swelling and redness
at the injection site due to sensitivity to thimerosal. Most importantly,
since 1999, newly formulated thimerosal preservative-free vaccines
have been licensed. With the newly formulated vaccines, the maximum
cumulative exposure during the first six months of life will now
be less than three micrograms of mercury. No children are receiving
toxic levels of mercury from vaccines.
|
Top |
What
research is being conducted by the Federal Government regarding
the safety of vaccines containing thimerosal?
There is no convincing scientific evidence to suggest that thimerosal in vaccines causes any health problems in children and adults beyond local hypersensitivity reactions (like redness and swelling at the injection site). However, efforts to remove thimerosal from the U.S. vaccine supply have been accompanied by research investigations to assess the potential health effects of exposure to thimerosal-containing vaccines.
The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) funds thimerosal research that focuses on better understanding of what happens to thimerosal once it is introduced into the body and how this compares to current knowledge of methyl mercury pathways.
- A recent study sponsored by the NIAID and conducted at the University of Rochester assessed mercury levels in 40 infants who received vaccines containing thimerosal and 21 infants who received thimerosal-free vaccines. The scientists measured the level of mercury in the infant's blood, urine, and stool up to 28 days after vaccination. They found: infants who were given vaccines with thimerosal had levels of mercury well below the safe level of 29 mmol/L (this level is set ten times lower than the level at which mercury begins to cause neurological problems); and the body seems to be able to get rid of thimerosal (ethylmercury)via the gastrointestinal tract (stools) much quicker than it gets rid of methylmercury. For more information about the different types of Mercury, visit Frequently Asked Questions About Mercury and Thimerosal.
- The Food and Drug Administration (FDA) has been actively addressing the issue of thimerosal as a preservative in vaccines. For more information, visit Thimerosal in Vaccines.
CDC's Center for Environmental Health and the National Center for Health Statistics are doing a study looking at all mercury exposures and working with the National Health and Nutrition Examination Survey (NHANES). NHANES 4 will collect samples of blood, hair, and urine from all women of reproductive age and children under 5 to assess mercury levels in the body from all sources of mercury a person can be exposed to in the environment. Findings of a study conducted using NHANES 3 data to check blood and hair mercury levels suggest that the mercury levels in young children and in women of childbearing age are generally below the level considered hazardous (MMWR) 50, 140-143. |
Top |
Does thimerosal cause autism?
There
is no conclusive evidence that any vaccine or vaccine additive
increases the risk of developing autism or any other behavior
disorder. Rather, evidence is accumulating of the lack of any
harm resulting from exposure to vaccine containing-thimerosal
as a preservative. In a 2004 report, the Institute of Medicine
(IOM) concluded that there is no association between autism and
vaccines that contain thimerosal as a preservative. Nonetheless,
given the level of concern among parents and others regarding
vaccines and autism, the CDC is committed to investigating this
issue to the fullest extent possible, using the best scientific
methods available.
For more information on autism and vaccines go to http://www.cdc.gov/od/science/iso/mmr_autism.htm.
|
Top |
Could thimerosal have been a factor
in Great Britain's rise in rates of autism in children born in
the 1980's and early 1990's?
It
is unlikely that the rapid increase in autism cases in the UK
was due to thimerosal. The only vaccine in the UK's childhood
immunization program that contains thimerosal is DTP. All other
vaccines (OPV, BCG, MMR, Hib, menC) added to the program since
the 1950's are and have always been thimerosal free. In addition,
if thimerosal in vaccines were causing autism, we would expect
to see a simultaneous increase in both thimerosal exposure and
autism cases. However, from the 1950's on, there was no increase
in the amount of thimerosal UK children were receiving from vaccines,
yet there was a jump in autism cases in the 1980's.
A significant change in the UK's program did occur in 1990, when they accelerated their immunization schedule so vaccines would be given earlier (changed fro m3, 5, and 8 months to 2, 3 and 4 months). However, the rate of autism was rising long before this change occurred (Fombonne, 2001).
|
|
|
Do those sensitive to mercury have problems
with thimerosal-containing vaccines?
Some individuals experience local skin reactions such as redness and swelling that may suggest a delayed-type of minor allergic reaction following injection with pr0ducts containing thimerosal. Research suggests that most people who have a contact or skin allergy to thimerosal will not have the reaction when thimerosal is injected under the skin (Forstrom, 1980; Jacobs,1982). A prior history of a minor reaction to thimerosal in a vaccine is not considered a contraindication to further vaccination with thimerosal-containing vaccines. Severe anaphylactic (allergic) reaction to any vaccine is a contraindication to further vaccination with the vaccine.
|
Top |
Do
measles, mumps, and rubella (MMR) vaccines contain thimerosal?
No,
MMR vaccine does not and never did contain thimerosal. Varicella
(chickenpox), inactivated polio (IPV), and pneumococcal conjugate
vaccines have also never contained thimerosal.
|
Top |
Why are chemicals and other substances
added to vaccines?
Many foods and medicines, including vaccines, have chemicals added
to them to prevent the growth of germs, reduce spoilage, and prevent
it from losing its potency over time. Some additives are used
in the production of vaccines. Vaccines may include suspending
fluid (e.g., sterile water, saline, or fluids containing protein);
preservatives and stabilizers (e.g., albumin, phenols, and glycine);
and adjuvants, or enhancers, that help the vaccine improve its
ability to protect against disease.
For more information on additives, go to: www.cdc.gov/vaccines/vac-gen/additives.htm. |
Top |
How can I find out what chemical additives
are in specific vaccines?
Ask your healthcare provider or pharmacist for a copy of the vaccine
package insert. The package insert lists ingredients in the vaccine
and discusses any known adverse reactions.
|
Top |
Which childhood
vaccines do not contain thimerosal?
Today, with the exception of some influenza vaccines, none of
the vaccines used to protect preschool children against 12 infectious
diseases contain thimerosal as a preservative. (Those with a concentration
of less than 0.0002% contain what is considered “trace”
or insignificant, amounts.) Certain Influenza (flu) vaccines and
tetanus-diphtheria vaccines (Td) given to children age 7 and older
contain thimerosal as a preservative. For more information on
thimerosal content in some currently manufactured U.S. licensed
vaccines, go to www.fda.gov/cber/vaccine/thimerosal.htm.
|
Top |
Why does some flu vaccine
contain thimerosal when the preservative has been removed from
other pediatric vaccines?
Influenza (flu) vaccine is a new addition to the recommended childhood
immunization schedule. The CDC recommends children 6 months through 18 years of age be vaccinated against flu each year. Inactivated
influenza vaccine for children 6-23 months of age is currently
available both with thimerosal as a preservative and preservative-free.
The removal of thimerosal as a preservative from influenza vaccine
is a complicated process. The total amount of flu vaccine without
thimerosal as a preservative will be increased as vaccine manufacturing
capabilities are expanded. In the meantime, it is important to
keep in mind the benefits of influenza vaccination outweight the
theoretical risk, if any, for exposure to thimerosal.
|
Top |
Why weren't thimerosal-containing vaccines
taken off the market?
Scientific data have not established that vaccines containing
thimerosal, used as a preservative, create an imminent or substantial
hazard to public health or are in violation of FDA
laws or regulations, and therefore do not justify such a recall.
A mandatory recall requires that the product present an
imminent or substantial hazard to the public health. The
U.S. FDA is responsible for voluntary and mandatory recalls of
drug and vaccine products. The FDA continuously monitors the safety
of these products.
|
Top |
Should immunization providers stop using licensed
pediatric vaccines that contain thimerosal?
No. Immunization providers should use the vaccines available in
their stock. The use of vaccines should continue according to
the currently recommended schedule. The risks of not vaccinating
children on time are significant, whereas the risks of thimerosal-containing
vaccines have not been proven scientifically. Furthermore, availability
of any vaccine containing thimerosal preservative is rare.
|
Top |
What is the availability of the preservative-free
hepatitis B vaccine?
All hepatitis B vaccines intended for use in infants and children
are free of thimerosal as a preservative, and an adequate supply
of these vaccines is available for all infant and childhood vaccinations.
This vaccine should be administered to all newborn infants and
is a major cornerstone in the prevention of a potentially fatal
disease in children and adults.
|
Top |
Are older lots of pediatric
vaccines which contain thimerosal as a preservative still on the
shelves in doctor's offices and being used in the U.S.?
With the exception of some influenza vaccines and tetanus-diptheria
(Td) vaccines (given to children age 7 and older), the last lots
of recommended childhood vaccine which contain thimerosal as a
preservative expired by early 2003. If providers have such expired
vaccines in their stocks, they should discard them.
Top |
|